Peptide Research Blends
Curated peptide blends used in research, with composition and pathway for each. No human clinical trials exist for most blends. For research purposes only.
Research purposes only. These are reference compositions, not medical advice. No human clinical trials exist for most combinations. Always follow applicable regulations in your jurisdiction.
Research Blends
Each blend combines compounds acting on related pathways. Composition is provided as reference only; no use, exposure or schedule is given.
GH Axis Blend
Peptides
Ipamorelin (ghrelin receptor agonist) with CJC-1295 without DAC (GHRH analogue): two compounds that bind separate pituitary receptors.
Tissue Repair Blend
Peptides
BPC-157 (pentadecapeptide) with TB-500 (thymosin beta-4 fragment). No human clinical trials exist for this combination.
Cellular Longevity Blend
Peptides
Ipamorelin (ghrelin receptor agonist) with Epitalon, a tetrapeptide from Khavinson's work studied for telomerase activity.
Neuro Blend
Peptides
Semax (ACTH(4-7) analogue) with Selank (tuftsin analogue), two heptapeptides developed in Russia.
Immune Blend
Peptides
Single compound: thymosin alpha-1, a 28-amino-acid peptide with an acetylated N-terminus.
Semaglutide Reference Blend
Peptides
Single compound: semaglutide, a GLP-1 receptor agonist with C18 fatty-acid acylation. Reference publication set: STEP programme.
Frequently Asked Questions
Background on how the blends are composed.
What is a peptide research blend?
A blend is a set of two or more compounds that act on related pathways, for example a ghrelin-receptor agonist (Ipamorelin) together with a GHRH analogue (CJC-1295), which bind to separate pituitary receptors.
Are these blends proven in humans?
Most blends shown here have limited or no human clinical trial data. Their composition is derived from published preclinical work. Individual peptides have varying levels of published human data: Semaglutide has Phase 3 trial publications (STEP), BPC-157 and TB-500 have only animal data. Always follow the regulations that apply in your jurisdiction.
How are the blends grouped?
By pathway. GH-axis blends contain compounds acting on growth hormone secretion receptors, the tissue blend contains BPC-157 and TB-500, metabolic blends contain incretin receptor agonists, and the neuro blend contains Semax and Selank.
Are these compositions recommendations?
No. They are reference compositions for laboratory research, not prescriptions and not recommendations for use. Milo-Lab gives no use or dosing advice.
Research Tools
Complete your research workflow.